Glucagon like Peptide 1 Receptor Agonist Market Insights Video
According to Cognitive Market Research, the global Glucagon like Peptide 1 Receptor Agonist market size was USD 23514.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 10.60% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 9405.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 7054.26 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 5408.27 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.6% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 1175.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 470.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2031.
The Hospital Pharmacies held the highest Glucagon like Peptide 1 Receptor Agonist market revenue share in 2024.
